Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (405)	9/5/2001 1:28:55 PM
From: nigel bates	Read Replies (1) \| Respond to of 1005

Another one to add to the list (though no US listing) - LONDON, Sept 5 (Reuters) - A block sale of 115,000 shares and a sharp markdown by market makers sent XTL Biopharmaceuticals Ltd (LSE: XTL.L - news) stock to a new low of 41 pence on Wednesday, dealers said. The Israeli biotechnology firm listed in London a year ago at 150 pence but has seen its shares fall heavily since. The company said it was unaware of any fundamental factors behind the latest decline. The shares were quoted off 17 percent at 46-1/2 by 1440 GMT. must be getting somewhere near cash xtlbio.com If it carries on down, I may get tempted. nig